8,300-share option exercise; multiple 10b5-1 sales reported (PHVS)

Rhea-AI Filing Summary

PHVS filed a Form 144 reporting proposed sales and an option exercise. The filing lists an exercise of stock options for 8,300 shares on 06/29/2026 for cash. It also lists multiple 10b5-1 sales by Anne Simonne J. Lesage and Graymatters Consulting on dates in April and June 2026, including transactions of 21,700 shares and 19,200 shares on 04/30/2026.

Insights

Securities Compliance Counsel

Form 144 discloses proposed resale activity and an option exercise by affiliated holders.

The filing records a proposed option exercise for 8,300 shares effective 06/29/2026 and multiple executed or reported 10b5-1 sales by named holders on dates in April and June 2026. The entries list share counts and gross proceeds per trade.

These disclosures are procedural notices required under resale rules; cash‑flow treatment is explicit where listed as cash for the exercise. Subsequent trading or settlement details would appear in follow‑on filings.

Key Figures

Option exercise: 8,300 shares 10b5-1 sale example: 21,700 shares 10b5-1 sale example: 19,200 shares +2 more

5 metrics

Option exercise 8,300 shares exercise of stock options on 06/29/2026

10b5-1 sale example 21,700 shares sale by Anne Simonne J. Lesage on 04/30/2026

10b5-1 sale example 19,200 shares sale by Graymatters Consulting on 04/30/2026

Sample proceeds $656,550.86 gross proceeds from 21,700-share sale on 04/30/2026

Sample proceeds $580,909.44 gross proceeds from 19,200-share sale on 04/30/2026

Key Terms

10b5-1, Form 144, Exercise of Stock Options

3 terms

10b5-1 regulatory

"10b5-1 Sales for ANNE SIMONNE J. LESAGE Emmy Noetherweg 2 Leiden"

A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.

Form 144 regulatory

"Filer Information | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Exercise of Stock Options financial

"Securities To Be Sold | Exercise of Stock Options | Issuer"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 06/29/2026 - 04:46 PM Accepted by SEC EDGAR 06/29/2026 - 04:45 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	8300	282283.00	65407822	06/29/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/29/2026	Exercise of Stock Options	Issuer			8300	06/29/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for ANNE SIMONNE J. LESAGE Emmy Noetherweg 2 Leiden P7 2333 BK	Common	06/25/2026	2300	80774.46
10b5-1 Sales for GRAYMATTERS CONSULTING Emmy Noetherweg 2 Leiden P7 2333 BK	Common	06/25/2026	2300	80785.59
10b5-1 Sales for ANNE SIMONNE J. LESAGE Emmy Noetherweg 2 Leiden P7 2333 BK	Common	04/30/2026	21700	656550.86
10b5-1 Sales for GRAYMATTERS CONSULTING Emmy Noetherweg 2 Leiden P7 2333 BK	Common	04/30/2026	19200	580909.44
10b5-1 Sales for ANNE SIMONNE J. LESAGE Emmy Noetherweg 2 Leiden P7 2333 BK	Common	04/29/2026	3700	111280.46
10b5-1 Sales for GRAYMATTERS CONSULTING Emmy Noetherweg 2 Leiden P7 2333 BK	Common	04/29/2026	3700	111229.40
10b5-1 Sales for ANNE SIMONNE J. LESAGE Emmy Noetherweg 2 Leiden P7 2333 BK	Common	04/23/2026	100	3003.00
10b5-1 Sales for GRAYMATTERS CONSULTING Emmy Noetherweg 2 Leiden P7 2333 BK	Common	04/23/2026	100	3003.00
10b5-1 Sales for ANNE SIMONNE J. LESAGE Emmy Noetherweg 2 Leiden P7 2333 BK	Common	04/22/2026	7500	225361.90
10b5-1 Sales for GRAYMATTERS CONSULTING Emmy Noetherweg 2 Leiden P7 2333 BK	Common	04/22/2026	7000	210357.70

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does PHVS's Form 144 report about insider transactions?

The filing reports a proposed exercise of stock options for 8,300 shares on 06/29/2026 and several 10b5-1 sales by named holders during April and June 2026, with listed share counts and gross proceeds.

Who executed the 10b5-1 sales listed in PHVS's Form 144?

The sales are attributed to Anne Simonne J. Lesage and Graymatters Consulting, with multiple trades on 04/22/2026, 04/29/2026, 04/30/2026, and 06/25/2026, each listing share counts and proceeds.

How many shares were involved in the largest 10b5-1 trades shown?

The excerpt shows a 21,700-share sale by Anne Simonne J. Lesage and a 19,200-share sale by Graymatters Consulting on 04/30/2026, with gross proceeds listed for each trade.

Does the Form 144 show how proceeds will be used by PHVS?

The filing shows the option exercise as being completed for cash, but it does not state any company use of proceeds; proceeds attribution beyond the listed cash indication is not provided in the excerpt.

Are these 10b5-1 sales routine disclosures for PHVS insiders?

The entries are reported as 10b5-1 sales, indicating planned trading arrangements; the filing lists dates, share counts, and gross proceeds, consistent with routine resale notifications.